Clinical Trial Update: First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency [Phase 1]

View source ↗

Summary

This is a first-in-human safety and ease-of-use study of a 400 mg progesterone product called Callavid for luteal phase insufficiency; the trial is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Luteal Phase Deficiency

Drugs mentioned

• Progesterone Callavid (progesterone)

Snippet

Sponsor: Calla Lily Clinical Care Ltd | Conditions: Luteal Phase Insuffiency, Progesterone Delivery | Phase 1 | Status: RECRUITING